Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...

Shares of Philip Morris ( NYSE: PM) snapped six straight sessions of gains, as the stock closed 0.74% down at $122.89 on ...

The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...

Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

FDA decision makes ZYN the first authorized ... 21+ Access Only Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI's U.S. affiliates are committed to responsible ...

WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International ... than a decade as FDA reviewed company ...

authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes. The pouches have been available for more than a decade as FDA reviewed company data intended to ...

The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.